← Back to Discover
Boxer Capital Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,327,787,255
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $339,990,606
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $93,640,000
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $80,622,300
- UNIQURE NV · SHS · N90064101 · shares: $69,241,998
- KODIAK SCIENCES INC · COM · 50015M109 · shares: $57,567,296
- KYMERA THERAPEUTICS INC · COM · 501575104 · shares: $49,204,897
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares: $46,969,440
- REPLIMUNE GROUP INC · COM · 76029N106 · shares: $44,091,810
- CELCUITY INC · COM · 15102K100 · shares: $43,577,368
- Q32 BIO INC · COM · 746964105 · shares: $40,122,209
Reported holdings
63 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 10,876,219 shares | $339,990,606 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 500,000 shares | $93,640,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 605,000 shares | $80,622,300 |
| UNIQURE NV | SHS | N90064101 | — | 1,503,300 shares | $69,241,998 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 1,477,600 shares | $57,567,296 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 429,100 shares | $49,204,897 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 998,500 shares | $46,969,440 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 3,983,000 shares | $44,091,810 |
| CELCUITY INC | COM | 15102K100 | — | 416,530 shares | $43,577,368 |
| Q32 BIO INC | COM | 746964105 | — | 3,149,310 shares | $40,122,209 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | — | 1,395,156 shares | $33,595,356 |
| PRECIGEN INC | COM | 74017N105 | — | 5,150,000 shares | $29,355,000 |
| CORCEPT THERAPEUTICS INC | COM | 218352102 | — | 335,500 shares | $29,171,725 |
| Surrozen Inc. | COM NEW | 86889P208 | — | 1,105,683 shares | $26,963,591 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 170,000 shares | $20,838,600 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 1,866,000 shares | $19,014,540 |
| VAXCYTE INC | COM | 92243G108 | — | 325,000 shares | $18,892,250 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 500,000 shares | $18,400,000 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 1,100,000 shares | $16,434,000 |
| PTC THERAPEUTICS INC | COM | 69366J200 | — | 200,000 shares | $16,314,000 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 46,457 shares | $15,553,339 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 800,000 shares | $14,368,000 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 1,300,000 shares | $12,766,000 |
| OPUS GENETICS INC | COM | 67577R102 | — | 2,815,000 shares | $11,569,650 |
| PALISADE BIO INC | COM | 696389402 | — | 4,799,875 shares | $10,031,739 |
| APOGEE THERAPEUTICS INC | COM | 03770N101 | — | 70,000 shares | $9,291,100 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 100,000 shares | $8,878,000 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 225,000 shares | $8,707,500 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 100,000 shares | $8,519,000 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 450,000 shares | $8,419,500 |
| CRESCENT BIOPHARMA INC. | COM | 38000Q201 | — | 453,686 shares | $8,166,348 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 494,000 shares | $8,096,660 |
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | 48669G303 | — | 560,000 shares | $7,884,800 |
| SHATTUCK LABS INC | COM | 82024L103 | — | 1,000,000 shares | $6,940,000 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 375,000 shares | $6,930,000 |
| FORTE BIOSCIENCES INC | COM NEW | 34962G208 | — | 274,500 shares | $5,833,125 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 842,106 shares | $5,827,374 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 275,000 shares | $5,354,250 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 900,000 shares | $5,310,000 |
| CYBIN INC | COM NEW | 23256X407 | — | 790,000 shares | $5,221,900 |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | — | 275,000 shares | $5,145,250 |
| IMMATICS N.V | SHS | N44445109 | — | 475,000 shares | $4,811,750 |
| FAETH THERAPEUTICS inc | COM NEW | 81728A207 | — | 180,505 shares | $4,512,625 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 75,000 shares | $4,025,250 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 350,000 shares | $3,790,500 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 749,035 shares | $3,625,329 |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | — | 2,000,000 shares | $3,400,000 |
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | — | 2,844,994 shares | $3,129,493 |
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | — | 1,500,000 shares | $3,120,000 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | — | 300,000 shares | $2,997,000 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 302,536 shares | $2,955,777 |
| CLENE INC | COM NEW | 185634201 | — | 477,515 shares | $2,939,105 |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | — | 150,000 shares | $2,695,500 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 75,000 shares | $2,688,000 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 100,000 shares | $2,426,000 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 70,000 shares | $2,271,850 |
| EDESA BIOTECH INC | COM NEW | 27966L306 | — | 205,000 shares | $1,666,650 |
| INVIVYD INC | COM | 00534A102 | — | 1,500,000 shares | $1,308,600 |
| UPSTREAM BIO INC | COM | 91678A107 | — | 150,000 shares | $1,038,000 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | — | 666,666 shares | $893,332 |
| PEPGEN INC | COM | 713317105 | — | 272,892 shares | $491,206 |
| REGENXBIO INC | COM | 75901B107 | — | 15,000 shares | $179,700 |
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | — | 66,666 shares | $1,067 |